3/30
02:00 pm
alny
New Data Presented at ACC.26 Further Support Benefits of Vutrisiran in ATTR-CM and Potential of Zilebesiran for Hypertension Management [Yahoo! Finance]
Low
Report
New Data Presented at ACC.26 Further Support Benefits of Vutrisiran in ATTR-CM and Potential of Zilebesiran for Hypertension Management [Yahoo! Finance]
3/30
01:00 pm
alny
New Data Presented at ACC.26 Further Support Benefits of Vutrisiran in ATTR-CM and Potential of Zilebesiran for Hypertension Management
Low
Report
New Data Presented at ACC.26 Further Support Benefits of Vutrisiran in ATTR-CM and Potential of Zilebesiran for Hypertension Management
3/26
03:44 am
alny
Alnylam (ALNY) Targets 25% CAGR with Innovative Therapies [Yahoo! Finance]
Low
Report
Alnylam (ALNY) Targets 25% CAGR with Innovative Therapies [Yahoo! Finance]
3/25
02:37 pm
alny
Alnylam Pharmaceuticals (ALNY) had its "buy" rating reaffirmed by Chardan Capital. They now have a $425.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals (ALNY) had its "buy" rating reaffirmed by Chardan Capital. They now have a $425.00 price target on the stock.
3/25
01:51 pm
alny
Alnylam Pharmaceuticals (ALNY) had its "buy" rating reaffirmed by HC Wainwright. They now have a $510.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals (ALNY) had its "buy" rating reaffirmed by HC Wainwright. They now have a $510.00 price target on the stock.
3/24
04:30 pm
alny
Alnylam Pharmaceuticals, Inc. (ALNY) Discusses Progress and Strategy in Transforming ATTR Amyloidosis Care and Expanding TTR Franchise Transcript [Seeking Alpha]
Medium
Report
Alnylam Pharmaceuticals, Inc. (ALNY) Discusses Progress and Strategy in Transforming ATTR Amyloidosis Care and Expanding TTR Franchise Transcript [Seeking Alpha]
3/24
08:03 am
alny
Alnylam Advances Future of ATTR-CM Care Through Strategic Collaboration with Viz.ai and Support for the American Heart Association [Yahoo! Finance]
Low
Report
Alnylam Advances Future of ATTR-CM Care Through Strategic Collaboration with Viz.ai and Support for the American Heart Association [Yahoo! Finance]
3/24
07:30 am
alny
Alnylam Advances Future of ATTR-CM Care Through Strategic Collaboration with Viz.ai and Support for the American Heart Association
Low
Report
Alnylam Advances Future of ATTR-CM Care Through Strategic Collaboration with Viz.ai and Support for the American Heart Association
3/20
12:11 pm
alny
Is Incyte Stock Outperforming the Dow? [Yahoo! Finance]
Low
Report
Is Incyte Stock Outperforming the Dow? [Yahoo! Finance]
3/16
08:43 am
alny
Alnylam Pharmaceuticals (ALNY) had its "hold" rating reaffirmed by Jefferies Financial Group Inc.. They now have a $330.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals (ALNY) had its "hold" rating reaffirmed by Jefferies Financial Group Inc.. They now have a $330.00 price target on the stock.
3/13
05:30 am
alny
Amvuttra (Medison Pharma, Alnylam Pharmaceuticals) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]
Low
Report
Amvuttra (Medison Pharma, Alnylam Pharmaceuticals) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]
3/12
07:39 am
alny
Tenaya Therapeutics (TNYA) Is Up 47.7% After Positive TN-301 DMD Data And Alnylam Deal [Yahoo! Finance]
Low
Report
Tenaya Therapeutics (TNYA) Is Up 47.7% After Positive TN-301 DMD Data And Alnylam Deal [Yahoo! Finance]
3/10
08:23 am
alny
Alnylam to Webcast TTR Investor Webinar [Yahoo! Finance]
Low
Report
Alnylam to Webcast TTR Investor Webinar [Yahoo! Finance]
3/10
08:00 am
alny
Alnylam to Webcast TTR Investor Webinar
Low
Report
Alnylam to Webcast TTR Investor Webinar
3/7
12:36 pm
alny
Alnylam Tenaya Cardiovascular RNAi Pact And What It Means For Valuation [Yahoo! Finance]
Low
Report
Alnylam Tenaya Cardiovascular RNAi Pact And What It Means For Valuation [Yahoo! Finance]
3/7
02:33 am
alny
A Look At Alnylam Pharmaceuticals (ALNY) Valuation After Recent Share Price Weakness [Yahoo! Finance]
Low
Report
A Look At Alnylam Pharmaceuticals (ALNY) Valuation After Recent Share Price Weakness [Yahoo! Finance]
3/6
05:14 pm
alny
Pfizer nabs first obesity approval; Alnylam, Tenaya search for heart drugs [Yahoo! Finance]
Low
Report
Pfizer nabs first obesity approval; Alnylam, Tenaya search for heart drugs [Yahoo! Finance]
3/6
07:32 am
alny
Alnylam and Tenaya sign $1.23bn cardiovascular target discovery deal [Yahoo! Finance]
Low
Report
Alnylam and Tenaya sign $1.23bn cardiovascular target discovery deal [Yahoo! Finance]
3/5
09:21 am
alny
Tenaya Therapeutics inks $1.13 billion deal with Alnylam for heart-disease treatments [Yahoo! Finance]
Low
Report
Tenaya Therapeutics inks $1.13 billion deal with Alnylam for heart-disease treatments [Yahoo! Finance]
3/5
09:18 am
alny
Helix Announces Multi-Year Agreement with Alnylam to Drive Precision Medicine Development [Yahoo! Finance]
Low
Report
Helix Announces Multi-Year Agreement with Alnylam to Drive Precision Medicine Development [Yahoo! Finance]
3/5
09:03 am
alny
Alnylam's research pact worth up to $1.1B sends Tenaya higher [Seeking Alpha]
Low
Report
Alnylam's research pact worth up to $1.1B sends Tenaya higher [Seeking Alpha]
3/4
06:48 pm
alny
Alnylam Reimbursement Win And Trial Progress Versus Current Valuation Signals [Yahoo! Finance]
Low
Report
Alnylam Reimbursement Win And Trial Progress Versus Current Valuation Signals [Yahoo! Finance]
3/2
11:52 pm
alny
Alnylam Pharmaceuticals Touts AMVUTTRA Momentum, Teases Key Pipeline Readouts at TD Cowen Conf. [Yahoo! Finance]
Low
Report
Alnylam Pharmaceuticals Touts AMVUTTRA Momentum, Teases Key Pipeline Readouts at TD Cowen Conf. [Yahoo! Finance]
3/2
04:12 pm
alny
Alnylam Pharmaceuticals, Inc. (ALNY) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
Low
Report
Alnylam Pharmaceuticals, Inc. (ALNY) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
3/2
04:34 am
alny
Oligonucleotides Global Markets, 2022-2024 & 2025-2030, Profiles of Major Players - Alnylam Pharmaceuticals, Biogen/Ionis Pharmaceuticals, Novartis, and Sarepta Therapeutics [Yahoo! Finance]
Low
Report
Oligonucleotides Global Markets, 2022-2024 & 2025-2030, Profiles of Major Players - Alnylam Pharmaceuticals, Biogen/Ionis Pharmaceuticals, Novartis, and Sarepta Therapeutics [Yahoo! Finance]